Plerixafor is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-alpha (SDF-1-alpha). This agent was approved on Dec. 15, 2008, as treatment in combination with gra
Molecular Weight:
502.78
Purity:
~90%
CAS Number:
[110078-46-1]
* VAT and and shipping costs not included. Errors and price changes excepted
